Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02941614 · ClinicalTrials.gov registry record
Implementing Systematic Distress Screening in Breast Cancer
A clinical trial of Breast Cancer, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 1,436
- Enrollment target
- 6
- Study locations
NCT02941614 is a study of Breast Cancer that has completed, run by Kaiser Permanente. The registered enrollment target is 1,436 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (49% lower). The trial reports 6 study locations across 1 state.
The verdict
NCT02941614, a study of Breast Cancer, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 1,436 participants
- Enrollment target
- 6
- Study locations
Study Summary
Many breast cancer patients experience psychological distress during their cancer care journey. There are effective treatments for breast cancer patients experiencing distress, such as individual or group therapy, health education, and medication. Unfortunately, clinicians may not be aware of the symptoms of distress in their breast cancer patients, and some breast cancer patients who could benefit from referral to behavioral health specialists are overlooked. New guidelines recommend that all cancer patients be regularly screened for distress. However, there are unanswered questions about the impact of distress screening conducted on a large scale. Few studies have evaluated the impact of distress screening on important outcomes in breast cancer patients, such as patient experience and use of health care services, as compared to the usual care offered by the health care organization. In addition, oncology clinicians may be uncertain about the benefits of large-scale distress screening, and pilot screening programs have not been uniformly successful particularly in the community oncology setting. The overarching goals of this study are to assess the effectiveness of implementing a guideline-recommended distress screening program for newly diagnosed breast cancer patients on improving identification and referral to treatment for highly distressed breast cancer patients, to assess patient-reported outcomes, health services utilization, and implementation outcomes of the program. This study will address two main research questions: 1) Evaluate the effectiveness of a guideline-recommended distress screening program for breast cancer patients in improving identification of distressed patients, initiation and completion of referrals to behavioral health, and patient-reported and utilization outcomes as compared to usual care; 2) Identify the barriers, facilitators, and other implementation-related outcomes related to distress screening in the community oncology setting.
Conditions Studied
Interventions
- BEHAVIORAL Distress screening
Study Locations (6)
California
- Anaheim Medical Center - Anaheim
- Baldwin Park Medical Center - Baldwin Park
- South Bay - Harbor City Medical Center - Harbor City
- Los Angeles Medical Center - Los Angeles
- West Los Angeles Medical Center - Los Angeles
- Woodland Hills Medical Center - Woodland Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,436 participants |
| Start Date | 2017-10-02 |
| Est. Completion | 2019-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02941614
The ClinicalTrials.gov registry entry for NCT02941614 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,436 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (49% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Distress screening is the first listed.
NCT02941614 reports 6 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02941614 about?
NCT02941614 is a clinical study titled "Implementing Systematic Distress Screening in Breast Cancer". Many breast cancer patients experience psychological distress during their cancer care journey. There are effective treatments for breast cancer patients experiencing distress, such as individual or group therapy, health education, and medication. Unfortunately, clinicians may not be aware of the sy...
What is the current status of trial NCT02941614?
This trial is currently completed. The enrollment target is 1,436 participants. The study started on 2017-10-02. Estimated completion is 2019-11-30.
What conditions does trial NCT02941614 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02941614?
The interventions under investigation include: Distress screening (BEHAVIORAL).
Who is sponsoring clinical trial NCT02941614?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02941614 being conducted?
This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.